GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambee Pharmaceuticals Plc (DHA:AMBEEPHA) » Definitions » Net Income From Continuing Operations

Ambee Pharmaceuticals (DHA:AMBEEPHA) Net Income From Continuing Operations : BDT0.00 Mil (TTM As of . 20)


View and export this data going back to 2004. Start your Free Trial

What is Ambee Pharmaceuticals Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Ambee Pharmaceuticals's net income from continuing operations for the six months ended in . 20 was BDT0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals Net Income From Continuing Operations Historical Data

The historical data trend for Ambee Pharmaceuticals's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambee Pharmaceuticals Net Income From Continuing Operations Chart

Ambee Pharmaceuticals Annual Data
Trend
Net Income From Continuing Operations

Ambee Pharmaceuticals Semi-Annual Data
Net Income From Continuing Operations

Ambee Pharmaceuticals Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals (DHA:AMBEEPHA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambee Pharmaceuticals Plc (DHA:AMBEEPHA) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:524322 BOM:524661 BOM:524572 BOM:531569 BOM:531210 BOM:526075 BOM:531762 BOM:524400 BOM:530057 BOM:524636 IMNPQ BOM:530207 BOM:523620 BOM:530665 BUD:NUTEX BOM:531173 BOM:530317 BOM:524752 BOM:532989 BOM:506919
Traded in Other Exchanges
N/A
Address
184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Website
https://www.ambeepharma.com
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.

Ambee Pharmaceuticals (DHA:AMBEEPHA) Headlines

No Headlines